Bio-Techne Corporation
TECH
$83.81
$0.9651.17%
03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
---|---|---|---|---|---|
Net Income | 49.06M | 27.47M | 50.99M | 75.48M | 70.22M |
Total Depreciation and Amortization | 27.31M | 27.80M | 28.54M | -17.38M | 26.97M |
Total Amortization of Deferred Charges | -- | -- | -- | 44.30M | -- |
Total Other Non-Cash Items | 3.29M | 9.07M | -173.00K | -8.14M | -7.26M |
Change in Net Operating Assets | 1.33M | 18.78M | -19.98M | -10.87M | -39.39M |
Cash from Operations | 80.99M | 83.12M | 59.38M | 83.39M | 50.54M |
Capital Expenditure | -16.44M | -14.86M | -13.59M | -10.83M | -11.75M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | 0.00 | -3.28M | -166.43M | 0.00 | 0.00 |
Divestitures | -- | -- | -- | 0.00 | 0.00 |
Other Investing Activities | 0.00 | -5.53M | 25.91M | 6.08M | -229.35M |
Cash from Investing | -16.44M | -23.67M | -154.11M | -4.76M | -241.10M |
Total Debt Issued | 0.00 | 65.00M | 160.00M | 0.00 | 170.00M |
Total Debt Repaid | -58.00M | -58.00M | -70.00M | -20.00M | 0.00 |
Issuance of Common Stock | 18.33M | 5.28M | 14.39M | 8.41M | 4.42M |
Repurchase of Common Stock | -168.00K | -81.12M | -20.23M | -39.00K | -11.00M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -12.58M | -12.56M | -12.65M | -12.60M | -12.58M |
Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
Cash from Financing | -52.42M | -81.40M | 71.51M | -24.22M | 150.84M |
Foreign Exchange rate Adjustments | -2.35M | 3.42M | -8.69M | -1.13M | 2.32M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 9.78M | -18.53M | -31.91M | 53.29M | -37.40M |